Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma

Enfortumab vedotin is a novel antibody–drug conjugate targeting Nectin-4, which is highly expressed in urothelial carcinoma. However, the expression status of Nectin-4 in upper tract urothelial carcinoma (UTUC) remains unclear. The relationship between Nectin-4 and Programmed Death Ligand 1 (PD-L1)...

Full description

Bibliographic Details
Main Authors: Eisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, Diana Taheri, Eri Banno, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Motohide Uemura, Tetsuya Takao, Seiji Yamaguchi, Hiroaki Fushimi, Kazuhiro Yoshimura, Hirotsugu Uemura, George J. Netto, Norio Nonomura
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
Nectin-4
Programmed Death Ligand 1
upper tract urothelial carcinoma
enfortumab vedotin
Online Access:https://www.mdpi.com/1422-0067/21/15/5390

Internet

https://www.mdpi.com/1422-0067/21/15/5390

Similar Items